Effect of Tripeptide Leu-Ile-Lys on the Course of Experimental Nephrolithiasis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We studied the effect of Leu-Ile-Lys tripeptide on the course of experimental oxalate nephrolithiasis modeled in rats by administration of 1% ethylene glycol solution instead of drinking water for 6 weeks. The Leu-Ile-Lys tripeptide obtained by chemical synthesis (purity ≥98%) was administered through a gastric tube (11.5 mg/kg in 1 ml saline). Administration of Leu-Ile-Lys tripeptide against the background of experimental oxalate nephrolithiasis significantly alleviated the course of experimental pathology, which was confirmed by typical biochemical and morphological changes: decrease in urinary activity of γ-glutamyltransferase (by 2.1 times in comparison with the initial level) and intensity of oxidative stress (the content of TBA-reactive products decreased by 1.3 times in comparison with that in untreated animals) and increase in glutathione peroxidase activity by 1.8 times; no histological signs of nephrolithiasis were found in animals treated with the tripeptide.

About the authors

A. Yu. Zharikov

Altai State Medical University, Ministry of Health of the Russian Federation

Author for correspondence.
Email: zharikov_a_y@mail.ru
Russian Federation, Barnaul

N. N. Yakushev

Altai State Medical University, Ministry of Health of the Russian Federation

Email: zharikov_a_y@mail.ru
Russian Federation, Barnaul

G. V. Zharikova

Altai State Medical University, Ministry of Health of the Russian Federation

Email: zharikov_a_y@mail.ru
Russian Federation, Barnaul

O. N. Mazko

Altai State Medical University, Ministry of Health of the Russian Federation

Email: zharikov_a_y@mail.ru
Russian Federation, Barnaul

O. G. Makarova

Altai State Medical University, Ministry of Health of the Russian Federation

Email: zharikov_a_y@mail.ru
Russian Federation, Barnaul

A. V. Lepilov

Altai State Medical University, Ministry of Health of the Russian Federation

Email: zharikov_a_y@mail.ru
Russian Federation, Barnaul

I. P. Bobrov

Altai State Medical University, Ministry of Health of the Russian Federation

Email: zharikov_a_y@mail.ru
Russian Federation, Barnaul


Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies